Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1993-06-21
1994-10-18
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
053569342
ABSTRACT:
The present invention provides a method of employing (R)-fluoxetine to treat sleep Apnea.
REFERENCES:
patent: 4018895 (1977-04-01), Molloy et al.
patent: 4035511 (1977-07-01), Messing et al.
patent: 4194009 (1980-03-01), Molloy et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4594358 (1986-06-01), Hynes
patent: 4698342 (1987-10-01), Crosby
patent: 4738973 (1988-04-01), Gittos
patent: 4843071 (1989-06-01), Hohenwarter
patent: 4918207 (1990-04-01), Brown et al.
patent: 5250571 (1993-10-01), Fuller et al.
Syvalahti et al., Current Therapeutic Research 25(2), 299 (1979).
Wong, et al., Biochemical Pharmacology, 32(7), 1287 (1983).
Hall, et al., Acta Pharmacol et toxicol., 54, 379 (1984).
Thomas et al., Psychopharmacology, 93, 193 (1987).
Neill et al., Psychopharmacology, 99(2), 196-201 (1989).
Fuller et al., Ser. No. 07/486,478 filed on Feb. 28, 1990.
Robertson et al., J. Med Chem., 31 1412 (1988).
Wong et al., Drug Development Research, 6, 397 (1985).
Fuller et al., Pharmacology Biochemistry and Behavior, 24 281 (1986).
Nash et al., Clin. Chem., 28(10), 2100 (1982).
Aronoff et al., Clin. Pharmacol. Ther., 36(1), 138 (1984).
Williams, et al., Sleep Disorders: Diagnosis and Treatment, John Wiley and Sons, (1988) Chapter 4.
Hospital Pharmacy, 24, 62-64 (1989).
Edwards, et al., Neuropsychopharmacology, 3(2), 129-136 (1990).
Mueller, et al., Acta Pharmacol. et toxicol., 47, 285-293 (1980).
Garner, et al., Am. Rev. Respir. Dis., 139, 946-950 (1989).
Mendelson, et al., Am. Rev. Respir. Dis., 141, 1527-1530 (1990).
Yoshioka, et al., J. Pharmacol. Exp. Ther., 260(2), 917-924 (1992).
Robertson David W.
Wong David T.
Eli Lilly and Company
Hollinden Gary E.
Jones Joseph A.
LandOfFree
Selected serotonin subtype receptor agonist to treat sleep apnea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selected serotonin subtype receptor agonist to treat sleep apnea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selected serotonin subtype receptor agonist to treat sleep apnea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2372869